Antimicrobial resistance is one of the major public health challenges affecting Nigeria today. It happens when bacteria viruses fungi or parasites change in ways that make medicines less effective against them. When this happens infections can become harder to treat patients may need longer care and healthcare costs can increase.

The statistics of antimicrobial resistance in nigeria help us understand how serious this problem has become. However AMR statistics are not only about counting infections and deaths. They also help health professionals understand resistance patterns identify gaps in treatment improve surveillance and develop better strategies for protecting effective medicines.

Understanding the AMR Situation in Nigeria

Nigeria has a large population and a healthcare system that includes primary health centres private hospitals specialist facilities teaching hospitals laboratories pharmacies and community healthcare services. Antimicrobial medicines are widely used across these settings.

However resistance does not develop in exactly the same way everywhere. The level of resistance can differ between hospitals communities regions patients and types of infections. This makes reliable and regular data very important.

Nigeria's Second One Health Antimicrobial Resistance National Action Plan also known as NAP 2.0 recognizes the need to improve AMR surveillance laboratory capacity diagnostics infection prevention antimicrobial stewardship research and public awareness. The plan covers the period from 2024 to 2028.

Key Statistics of Antimicrobial Resistance in Nigeria

One of the most important figures available comes from estimates for 2019.

Nigeria's NAP 2.0 reports that there were approximately 64500 deaths attributable to antimicrobial resistance in Nigeria in 2019. It also reports approximately 263400 deaths associated with AMR during the same year. The national action plan notes that the actual burden may be underestimated because of gaps in national AMR surveillance.

These two figures should not be confused. Attributable deaths and associated deaths describe different measures of the AMR burden.

The figures show why antimicrobial resistance deserves serious attention from healthcare professionals government agencies researchers and the wider public. At the same time they should be interpreted carefully because they are estimates rather than a complete record of every AMR-related death in the country.

Why AMR Statistics Matter

Statistics give healthcare professionals and decision-makers evidence that can guide action.

For example if surveillance shows that a particular bacterium is becoming resistant to a commonly used antibiotic doctors and hospitals can review treatment practices. They can also strengthen antimicrobial stewardship programs and encourage appropriate laboratory testing.

AMR statistics can help answer important questions. Which bacteria are becoming resistant? Which medicines are still effective? Which infections are creating the greatest concern? Are resistance patterns changing over time?

Without reliable answers to these questions it becomes more difficult to plan an effective response.

Good statistics can also help governments decide where laboratory services healthcare training infection prevention programs and surveillance resources are most needed.

The Challenge of AMR Data Collection

One of the biggest challenges when discussing the statistics of antimicrobial resistance in nigeria is that data are not equally available from every part of the country.

Some healthcare facilities have laboratories that can perform bacterial cultures and antimicrobial susceptibility testing. Other facilities may have limited laboratory capacity or may not routinely conduct these tests.

There can also be differences in access to trained laboratory professionals equipment reagents quality control systems and reporting platforms.

Research studies can provide valuable information but many studies are conducted in specific hospitals or regions. Therefore their findings may not always represent the entire Nigerian population.

This creates an important problem: a lack of reported resistance does not necessarily mean that resistance is absent or low. Sometimes it means that infections are simply not being tested or reported.

Common Resistant Bacteria

Several bacterial organisms are important when looking at antimicrobial resistance.

Escherichia coli commonly known as E. coli can cause urinary tract infections bloodstream infections and other illnesses. Some strains can become resistant to several commonly used antibiotics.

Klebsiella pneumoniae is another important bacterium. It can cause pneumonia bloodstream infections urinary tract infections and other serious illnesses. Resistant strains can make these infections more difficult to manage.

Staphylococcus aureus can cause skin infections and more serious infections. Some strains have developed resistance to antibiotics that are commonly used to treat bacterial infections.

Other organisms including Pseudomonas aeruginosa and Acinetobacter species can also develop resistance to multiple medicines and create serious challenges in healthcare facilities.

Resistance levels can vary from one location to another which is why national and local surveillance are both necessary.

AMR Surveillance and Better Data

AMR surveillance is the process of collecting analyzing and monitoring information about antimicrobial resistance.

Strong surveillance helps health authorities understand changes in resistance patterns. It can show whether certain bacteria are becoming harder to treat and whether specific medicines are becoming less effective.

Surveillance also supports antimicrobial stewardship. When healthcare professionals have reliable information about local resistance patterns they can make more informed treatment decisions.

WHO describes surveillance as an important tool for understanding the extent of AMR identifying trends and emerging threats setting intervention targets and measuring the impact of actions taken.

Nigeria is continuing to strengthen this area. In December 2025 Nigeria launched planning for its first nationally representative AMR survey with support from WHO and other partners. The survey is designed to generate stronger national evidence on AMR and improve the country's surveillance capacity.

The Impact of AMR on Healthcare

The statistics of AMR represent real patients and real challenges for healthcare facilities.

When an antimicrobial medicine does not work treatment may need to be changed. Patients may require additional laboratory tests alternative medicines or longer periods of care.

Longer treatment can increase costs for families and healthcare facilities. Patients may also spend more time away from work education and normal activities.

Hospitals can face additional pressure when resistant infections require longer stays or more complex treatment. Healthcare workers may also have to manage infections that would normally be easier to treat.

AMR can become particularly concerning for vulnerable patients including newborns older adults patients with weakened immune systems and people undergoing major medical procedures.

Responsible Antimicrobial Use Can Reduce the Problem

Better statistics are important but data alone cannot stop antimicrobial resistance. The information needs to lead to practical action.

Antimicrobial stewardship is an important part of this response. It encourages healthcare professionals to use antimicrobial medicines only when they are appropriate and to select the right medicine dose and duration.

Patients also have a role to play. Antibiotics should not be taken without appropriate medical advice. People should not share antibiotics with others or use leftover medicines for a new illness.

It is also important to remember that antibiotics do not treat viral infections. Taking antibiotics when they are not needed can contribute to unnecessary antimicrobial exposure and resistance.

Nigeria's National Response to AMR

Nigeria's response to AMR is based on a One Health approach. This recognizes that human health animal health agriculture food systems and the environment are connected.

The country's NAP 2.0 provides a framework for action between 2024 and 2028. Its priorities include improving surveillance strengthening infection prevention and control promoting responsible antimicrobial use improving diagnostics supporting research increasing public awareness and strengthening coordination.

This approach is important because antimicrobial resistance does not remain within one sector. Resistant microorganisms can move between people animals food and the environment.

The Role of NNAST

The Nigerian National Antimicrobial Stewardship TaskForce (NNAST) supports efforts to improve antimicrobial stewardship and strengthen the national response to AMR.

Education and awareness are important parts of this work. Healthcare professionals researchers policymakers and communities need reliable information to understand resistance and make responsible decisions about antimicrobial use.

NNAST also supports greater awareness of surveillance infection prevention research diagnostics and antimicrobial stewardship. These areas can work together to help Nigeria respond more effectively to the growing AMR challenge.

Conclusion

The statistics of antimicrobial resistance in nigeria provide an important picture of the country's AMR burden. The estimated 64500 AMR-attributable deaths and 263400 AMR-associated deaths reported for 2019 demonstrate the seriousness of the challenge. However these figures also need to be viewed alongside the gaps that remain in national surveillance and data collection.

Nigeria needs continued investment in laboratories diagnostics surveillance infection prevention research antimicrobial stewardship and public education. Reliable data can help identify changing resistance patterns and guide better healthcare decisions.

With stronger surveillance and responsible antimicrobial use Nigeria can improve its ability to prevent and control antimicrobial resistance. Continued collaboration among healthcare professionals government institutions researchers communities and organizations such as NNAST will be essential for protecting effective medicines and improving health outcomes for future generations.